Wound dressings, apparatus, and methods for controlling severe, life-threatening bleeding

a technology of wound dressings and bandages, applied in the field of advanced hemorrhage control bandages, can solve the problems of no low cost wound dressings that address or any wound dressings, bleeding can be fatal in ballistic injuries, severe arterial lacerations, etc., and achieve the effect of low cost and low cos

Inactive Publication Date: 2008-03-13
PROVIDENCE HEALTH SYST OREGON
View PDF3 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0018] The invention is directed to a first-aid / primary intervention wound dressing for control of severe, life-threatening bleeding. The subject wound dressing is typically relatively low cost. Presently there are no low cost wound dressings that address or any wound dressings that are suitable for control of severe life-threatening bleeding. Such bleeding can be fatal in ballistic injuries and severe arterial lacerations. There is an urgent need for this type of dressing especially in the battlefield where typically 50% of all deaths are associated with an inability to immediately control severe bleeding.

Problems solved by technology

Presently there are no low cost wound dressings that address or any wound dressings that are suitable for control of severe life-threatening bleeding.
Such bleeding can be fatal in ballistic injuries and severe arterial lacerations.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Wound dressings, apparatus, and methods for controlling severe, life-threatening bleeding
  • Wound dressings, apparatus, and methods for controlling severe, life-threatening bleeding
  • Wound dressings, apparatus, and methods for controlling severe, life-threatening bleeding

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0073] Table 1 provides a list of the main chitosan materials acquired for hemorrhage control testing. With the exception of the Gelfoam™+thrombin, and Surgicel™ controls for swine spleen experiments and the Johnson and Johnson 4×4 gauze control for use in swine aortic perforations, the dressing materials were all chitosan-based.

[0074] Aqueous solutions (2.00% w / w) were prepared in clean, sterile, 1 liter Pyrex flasks from Ametek UF water and dry chitosan. In the case of the Carbomer, Primex and Genis chitosan materials, 1.0% or 2.0% w / w of glacial acetic acid (Aldrich 99.99%) was added to the aqueous mixtures. Dissolution was achieved by shaking of the flask at 40° C. for 12 to 48 hours. The solutions were degassed by application of vacuum at 500 mTorr at room temperature immediately prior to freezing.

[0075] Wound dressings were prepared from the 2% aqueous solutions of chitosan that were poured into Teflon™ coated aluminum or polystyrene molds to at least 1.5 cm deep and frozen ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
systolic blood pressureaaaaaaaaaa
volumeaaaaaaaaaa
pore diametersaaaaaaaaaa
Login to view more

Abstract

A chitosan biomaterial is frozen in aqueous solution to form a frozen chitosan structure from which water is removed by a prescribed freeze-drying process to form a sponge-like chitosan structure having a thickness and a density. The sponge-like chitosan structure is compressed by application of heat and pressure to reduce the thickness and increase the density of the sponge-like chitosan structure to form a densified chitosan structure. The densified chitosan structure is further preconditioned by heating the densified chitopsan structure according to prescribed conditions to form a wound dressing. The wound dressing possesses an adhesion strength and resistance to dissolution in high blood flow bleeding situations.

Description

RELATED APPLICATIONS [0001] This application is a divisional of co-pending U.S. patent application Ser. No. 10 / 480,827, filed Oct. 6, 2004, which is a United States national stage application designated under 35 U.S.C. §371 of PCT / US02 / 18757, filed Jun. 14, 2002, which claims the benefit of U.S. Provisional Patent Application Ser. No. 60 / 298,773, filed Jun. 12, 2001, which are each incorporated herein by reference.NOTICE [0002] The U.S. Government has a paid-up license in this invention and the right in limited circumstances to license others on reasonable terms as provided by the terms of Grant No. DAMD17-98-1-8654 awarded by the Army / MRMC—Medical Research and Material Command.BACKGROUND OF THE INVENTION [0003] An advanced hemorrhage control bandage and methods of its application would substantially augment available hemostatic methods. To date, the application of continuous pressure with gauze bandage remains the preferred primary intervention technique used to stem blood flow, es...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61F13/53A01N43/04A61K38/17A61F13/00A61F13/15A61L15/16A61L15/28A61L15/42A61L33/08
CPCA61F13/00012A61F13/00034A61L2400/04A61F13/00987A61F13/00995A61F13/15203A61F2013/00106A61F2013/00463A61F2013/00468A61F2013/00472A61F2013/00536A61F2013/0054A61F2013/00931A61L15/28A61L15/425C08L5/08A61L15/32
Inventor GREGORY, KENTON W.MCCARTHY, SIMON J.
Owner PROVIDENCE HEALTH SYST OREGON
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap